More than one-quarter of children hospitalised with 2009 novel influenza A(H1N1) required intensive care or died, according to new research from the United States.
Monthly Archives: December 2010
Maternal exposure to mobile phones is linked to children’s behavioural problems
Pregnant mums who regularly use mobile phones may be more likely to have children with behavioural problems, particularly if those children start using mobile phones early themselves, suggests research published online in the Journal of Epidemiology and Community Health.
Study finds unrelated infections in research subjects
In about 40 per cent of research participants undergoing medical imaging, radiologists may detect an infection or tumour unrelated to the study but that may be meaningful to the individual’s health, according to a new report.
Five festive wines
’Tis the season to be jolly, sit back and enjoy some fine wines at a reasonable post-IMF bailout price, says Giovanni Morelli “The Supreme Court in America has ruled that they cannot have a nativity scene in Washington DC.
Pain relief versus adverse effects – striking a balance
A meeting on breakthrough pain held last month in Dublin heard from Italian expert Prof Sebastiano Mercadante on the best treatment options.
Consultants seek contract transfer
By Gary Culliton gary.
Human rights violated by abortion ban
By Lloyd Mudiwa lloyd.
Risks remain for children after PCV7 vaccination
Despite widespread use of pneumococcal vaccination, some children may still develop deafness following pneumococcal meningitis, according to new research.
A new approach to managing depression
GPs recently received an update on a new innovation in the treatment of depression at a special meeting in Dublin recently, held by Servier and with a presentation by leading psychiatrists including Professor Sidney Kennedy, Professor of Psychiatry at the University of Toronto, Canada.
Benefits of cancer drug confirmed
The latest data from one of the world’s largest and longest-running adjuvant aromatase inhibitor (AI) studies in postmenopausal women with early breast cancer provide further confirmation of the long-term superior efficacy and established safety profile of anastrozole over tamoxifen – even beyond treatment completion.